Free Daily Analysis

Stock Trend Analysis Report

Prepared for you on Tuesday, December 5, 2023.

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)

Crossroads (+60) - BCLI is struggling to move into a solid trend. Beware of choppy markets and consider a sidelines position until a stronger trend is identified.

Is it time to buy, sell, or avoid BCLI?

MarketClub looks at technical strength and momentum to determine if the timing is right for BCLI.

Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.

Open High Low BCLI Price Change
0.440 0.450 0.298 0.300 -0.100
Entry Signal

MarketClub’s Trade Triangles for BCLI

long term down The long-term trend has been DOWN since Jul 6th, 2023 at 1.9800

intermediate term up The intermediate-term trend has been UP since Nov 13th, 2023 at 0.1833

short term up The short-term trend has been UP since Nov 30th, 2023 at 0.2450

Smart Scan Analysis for BCLI

Based on our trend formula, BCLI is rated as a +60 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).

Smart Scan Analysis for BCLI
Strong Downtrend Sideways Strong Uptrend
Open High Low Price Change
0.440 0.450 0.298 0.300 -0.100
Prev. Close Volume Bid Ask Time
0.400 12392224 2023-12-05 15:59:55
Year High5.35Year High Date2018-06-04
Year Low2.88Year Low Date2018-02-09
52wk High3.4652wk High Date2023-03-31
52wk Low0.13452wk Low Date2023-10-31
Year End Close0.223Average Volume3,226,051
Shares Outstanding48,982% Institutional19.6
Market Cap91MAssets5,747,000M
Liabilities9,629,000MP/E Ratio-0.34730000
Get a free daily analysis and signals for Brainstorm Cell Therapeutics Inc. (BCLI) - Request Your Free Report.